Matsumoto Hironori, Takeba Jun, Umakoshi Kensuke, Nakabayashi Yuki, Moriyama Naoki, Annen Suguru, Ohshita Muneaki, Kikuchi Satoshi, Sato Norio, Aibiki Mayuki
Graduate School of Medicine, Department of Emergency and Critical Care Medicine, Ehime University, Shitsukawa 454, Toon, Ehime 791-0295 Japan.
J Intensive Care. 2019 Jan 15;7:2. doi: 10.1186/s40560-019-0359-3. eCollection 2019.
Heat stroke induces coagulofibrinolytic activation, which leads to life-threatening disseminated intravascular coagulation (DIC). However, treatment strategies for DIC in heat stroke have not yet been established, and also, the time course changes in coagulofibrinolytic markers have not been thoroughly evaluated. We report a severe heat stroke case with DIC who was eventually saved by anti-DIC treatments in accordance with changes in coagulofibrinolytic markers.
A 45-year-old man was found unconscious outside, and his body temperature was elevated to 41.9 °C. For heat stroke, we performed an immediate tracheal intubation under the general anesthesia along with cooling by iced gastric lavage, cold fluid administration, and an intravascular cooling using Thermogard™. About 4 h after admission, his core temperature fell to 37 °C. We assessed coagulofibrinolytic biomarkers and treated in accordance with changes in these parameters. This case exhibited a biphasic change varying from an enhanced to a suppressed fibrinolytic type of DIC depending on the relative balance between fibrinolytic activation and the level of plasminogen activator inhibitor-1 (PAI-1). In the early phase with consumption coagulopathy and enhanced fibrinolysis, we transfused a large amount of fresh frozen plasma (FFP) and platelets with tranexamic acid, an antifibrinolytic agent, possibly providing relief for the bleeding tendency. Anticoagulant therapy using recombinant human thrombomodulin-α (rh-TM-α) and antithrombin III (ATIII) concentrate was especially effective for DIC with a suppressed fibrinolytic phenotype in the later phase, after which organ failure that included severe hepatic failure was remarkably improved.
The present case may indicate the clinical significance of monitoring coagulifibrinolytic changes and the potential benefits of anticoagulants for heat stroke-induced DIC.
热射病可诱导凝血纤溶激活,进而导致危及生命的弥散性血管内凝血(DIC)。然而,热射病合并DIC的治疗策略尚未确立,并且凝血纤溶标志物的时间进程变化也未得到充分评估。我们报告1例严重热射病合并DIC患者,根据凝血纤溶标志物的变化采用抗DIC治疗最终获救。
一名45岁男性被发现昏迷在户外,体温升至41.9°C。对于热射病,我们在全身麻醉下立即进行气管插管,并通过冰水洗胃、输注冷液体以及使用Thermogard™进行血管内降温。入院约4小时后,他的核心体温降至37°C。我们评估了凝血纤溶生物标志物,并根据这些参数的变化进行治疗。该病例表现出双相变化,根据纤溶激活与纤溶酶原激活物抑制剂-1(PAI-1)水平之间的相对平衡,从增强型纤溶DIC转变为抑制型纤溶DIC。在早期消耗性凝血病和纤溶增强阶段,我们输注了大量新鲜冰冻血浆(FFP)和血小板,并使用抗纤溶药物氨甲环酸,这可能缓解了出血倾向。使用重组人血栓调节蛋白-α(rh-TM-α)和抗凝血酶III(ATIII)浓缩物进行抗凝治疗对后期纤溶表型受抑制的DIC特别有效,此后包括严重肝衰竭在内的器官功能衰竭得到显著改善。
本病例可能表明监测凝血纤溶变化的临床意义以及抗凝剂对热射病诱导的DIC的潜在益处。